semaglutide and the heart FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection Semaglutide ameliorates pressure overload-induced cardiac

Having scheduled small meals with high protein and steady fluids can reduce symptom severity more effectively than random snacking

September-October 2023

The information is a result of practice experience and research by the author

Furthermore, some governments in Europe have explicitly asked clinicians not to prescribe GLP-1s for obesity and instead reserve them for people with Type 2 diabetes

Patients with blood vessel problems show much higher rates of retained stomach contents (15% versus 2%) [6]

This medication is highly teratogenic (can cause birth defects) and requires participation in the MHRA Pregnancy Prevention Programme for women of childbearing potential, along with regular monitoring of blood tests